Standalone Non-Imaging Vibration-Controlled Ultrasound System

Description

NHS Supply Chain intends to launch a National Framework Agreement for the provision of Ultrasound System to Quantify Liver and or Spleen Stiffness and Measure Liver Steatosis that includes the following. • The ability to measure liver stiffness to quantify fibrosis and cirrhosis. • The ability to measure fatty liver to quantify steatosis non-invasively. • The functionality of Vibration-Controlled Transient Elastography (VCTE) technology. • The ability to allow any clinical practitioners to use the system rather than a trained sonographer only. For the avoidance of doubt consumables will only be in scope of the proposed Framework if purchased alongside the types of equipment, as stated in any subsequent specification. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £17,500,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. The estimated value over the total Framework Agreement term (including any extension options) is anticipated to be in the region of £35,000,000. NHS Supply Chain engaged with suppliers that can provide a Standalone Non-Imaging Vibration-Controlled Ultrasound System to Quantify Liver and or Spleen Stiffness and Measure Liver Steatosis. The PIN 2024/S 000-039307 intended to identify such providers with a view to ultimately align this solution within the scope of Endoscopy and Ultrasound Framework which is due for renewal in November 2026. Suppliers capable of delivering such a solution have been invited to submit proposals to provide a route to market that enables access for the NHS during the interim period until the award of the new framework on 2nd November 2026. Lot 1: This market exercise will be for the provision of a Standalone Non-Imaging Vibration-Controlled Ultrasound System to Quantify Liver and or Spleen Stiffness and Measure Liver Steatosis that includes the following. • The ability to measure liver stiffness to quantify fibrosis and cirrhosis. • The ability to measure fatty liver to quantify steatosis non-invasively. • The functionality of Vibration-Controlled Transient Elastography (VCTE) technology. • The ability to allow any clinical practitioners to use the system rather than a trained sonographer only.